UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 133 filers reported holding UNIQURE NV in Q1 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,162,000 | -6.7% | 34,500 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $1,246,000 | -2.0% | 34,500 | 0.0% | 0.01% | -22.2% |
| Q3 2020 | $1,271,000 | -18.3% | 34,500 | 0.0% | 0.02% | -18.2% |
| Q2 2020 | $1,555,000 | +4.0% | 34,500 | +9.5% | 0.02% | -24.1% |
| Q1 2020 | $1,495,000 | -27.8% | 31,500 | +9.0% | 0.03% | -12.1% |
| Q4 2019 | $2,071,000 | +70.3% | 28,900 | -6.5% | 0.03% | +43.5% |
| Q3 2019 | $1,216,000 | -43.6% | 30,900 | +12.0% | 0.02% | -37.8% |
| Q2 2019 | $2,157,000 | -5.6% | 27,600 | -27.9% | 0.04% | -70.6% |
| Q1 2019 | $2,285,000 | +693.4% | 38,300 | +283.0% | 0.13% | +563.2% |
| Q4 2018 | $288,000 | -60.2% | 10,000 | -49.7% | 0.02% | -58.7% |
| Q3 2018 | $724,000 | -5.2% | 19,900 | -1.5% | 0.05% | -29.2% |
| Q2 2018 | $764,000 | – | 20,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |